Global Veterinary Artificial Reproduction Market Insights, Forecast to 2031

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Veterinary Artificial Reproduction Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
  • 1.2.2 Artificial Insemination
  • 1.2.3 In Vitro Fertilization
  • 1.2.4 Embryo Transfer
  • 1.2.5 Other
• 1.3 Market by Application
  • 1.3.1 Global Veterinary Artificial Reproduction Market Share by Application: 2020 VS 2024 VS 2031
  • 1.3.2 Livestock
  • 1.3.3 Companion Animal
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Veterinary Artificial Reproduction Market Perspective (2020-2031)
• 2.2 Global Veterinary Artificial Reproduction Growth Trends by Region
  • 2.2.1 Global Veterinary Artificial Reproduction Market Size by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Veterinary Artificial Reproduction Market Size by Region (2020-2031)
• 2.3 Veterinary Artificial Reproduction Market Dynamics
  • 2.3.1 Veterinary Artificial Reproduction Industry Trends
  • 2.3.2 Veterinary Artificial Reproduction Market Drivers
  • 2.3.3 Veterinary Artificial Reproduction Market Challenges
  • 2.3.4 Veterinary Artificial Reproduction Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Veterinary Artificial Reproduction by Players
  • 3.1.1 Global Veterinary Artificial Reproduction Revenue by Players (2020-2025)
  • 3.1.2 Global Veterinary Artificial Reproduction Revenue Market Share by Players (2020-2025)
• 3.2 Global Veterinary Artificial Reproduction Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Veterinary Artificial Reproduction, Ranking by Revenue, 2023 VS 2024 VS 2025
• 3.4 Global Market Concentration Ratio
  • 3.4.1 Global Veterinary Artificial Reproduction Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Veterinary Artificial Reproduction Revenue in 2024
• 3.5 Global Key Players of Veterinary Artificial Reproduction Head office and Area Served
• 3.6 Global Key Players of Veterinary Artificial Reproduction, Product and Application
• 3.7 Global Key Players of Veterinary Artificial Reproduction, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

• 4.1 Global Veterinary Artificial Reproduction Historic Market Size by Type (2020-2025)
• 4.2 Global Veterinary Artificial Reproduction Forecasted Market Size by Type (2026-2031)

5 Breakdown Data by Application

• 5.1 Global Veterinary Artificial Reproduction Historic Market Size by Application (2020-2025)
• 5.2 Global Veterinary Artificial Reproduction Forecasted Market Size by Application (2026-2031)

6 North America

• 6.1 North America Veterinary Artificial Reproduction Market Size (2020-2031)
• 6.2 North America Market Size by Type
  • 6.2.1 North America Veterinary Artificial Reproduction Market Size by Type (2020-2031)
  • 6.2.2 North America Veterinary Artificial Reproduction Market Share by Type (2020-2031)
• 6.3 North America Market Size by Application
  • 6.3.1 North America Veterinary Artificial Reproduction Market Size by Application (2020-2031)
  • 6.3.2 North America Veterinary Artificial Reproduction Market Share by Application (2020-2031)
• 6.4 North America Market Size by Country
  • 6.4.1 North America Veterinary Artificial Reproduction Market Size by Country: 2020 VS 2024 VS 2031
  • 6.4.2 North America Veterinary Artificial Reproduction Market Size by Country (2020-2031)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Veterinary Artificial Reproduction Market Size (2020-2031)
• 7.2 Europe Market Size by Type
  • 7.2.1 Europe Veterinary Artificial Reproduction Market Size by Type (2020-2031)
  • 7.2.2 Europe Veterinary Artificial Reproduction Market Share by Type (2020-2031)
• 7.3 Europe Market Size by Application
  • 7.3.1 Europe Veterinary Artificial Reproduction Market Size by Application (2020-2031)
  • 7.3.2 Europe Veterinary Artificial Reproduction Market Share by Application (2020-2031)
• 7.4 Europe Market Size by Country
  • 7.4.1 Europe Veterinary Artificial Reproduction Market Size by Country: 2020 VS 2024 VS 2031
  • 7.4.2 Europe Veterinary Artificial Reproduction Market Size by Country (2020-2025)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 China

• 8.1 China Veterinary Artificial Reproduction Market Size (2020-2031)
• 8.2 China Market Size by Type
  • 8.2.1 China Veterinary Artificial Reproduction Market Size by Type (2020-2031)
  • 8.2.2 China Veterinary Artificial Reproduction Market Share by Type (2020-2031)
• 8.3 China Market Size by Application
  • 8.3.1 China Veterinary Artificial Reproduction Market Size by Application (2020-2031)
  • 8.3.2 China Veterinary Artificial Reproduction Market Share by Application (2020-2031)

9 Asia (excluding China)

• 9.1 Asia Veterinary Artificial Reproduction Market Size (2020-2031)
• 9.2 Asia Market Size by Type
  • 9.2.1 Asia Veterinary Artificial Reproduction Market Size by Type (2020-2031)
  • 9.2.2 Asia Veterinary Artificial Reproduction Market Share by Type (2020-2031)
• 9.3 Asia Market Size by Application
  • 9.3.1 Asia Veterinary Artificial Reproduction Market Size by Application (2020-2031)
  • 9.3.2 Asia Veterinary Artificial Reproduction Market Share by Application (2020-2031)
• 9.4 Asia Market Size by Region
  • 9.4.1 Asia Veterinary Artificial Reproduction Market Size by Region: 2020 VS 2024 VS 2031
  • 9.4.2 Asia Veterinary Artificial Reproduction Market Size by Region (2020-2031)
  • 9.4.3 Japan
  • 9.4.4 South Korea
  • 9.4.5 China Taiwan
  • 9.4.6 Southeast Asia
  • 9.4.7 India
  • 9.4.8 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Veterinary Artificial Reproduction Market Size (2020-2031)
• 10.2 Middle East, Africa, and Latin America Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Veterinary Artificial Reproduction Market Size by Type (2020-2031)
  • 10.2.2 Middle East, Africa, and Latin America Veterinary Artificial Reproduction Market Share by Type (2020-2031)
• 10.3 Middle East, Africa, and Latin America Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Veterinary Artificial Reproduction Market Size by Application (2020-2031)
  • 10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
• 10.4 Middle East, Africa, and Latin America Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Veterinary Artificial Reproduction Market Size by Country: 2020 VS 2024 VS 2031
  • 10.4.2 Middle East, Africa, and Latin America Veterinary Artificial Reproduction Market Size by Country (2020-2031)
  • 10.4.3 Brazil
  • 10.4.4 Mexico
  • 10.4.5 Turkey
  • 10.4.6 Saudi Arabia
  • 10.4.7 Israel
  • 10.4.8 GCC Countries

11 Key Players Profiles

• 11.1 Zoetis
  • 11.1.1 Zoetis Company Details
  • 11.1.2 Zoetis Business Overview
  • 11.1.3 Zoetis Veterinary Artificial Reproduction Introduction
  • 11.1.4 Zoetis Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.1.5 Zoetis Recent Development
• 11.2 Genus
  • 11.2.1 Genus Company Details
  • 11.2.2 Genus Business Overview
  • 11.2.3 Genus Veterinary Artificial Reproduction Introduction
  • 11.2.4 Genus Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.2.5 Genus Recent Development
• 11.3 Merck Animal Health
  • 11.3.1 Merck Animal Health Company Details
  • 11.3.2 Merck Animal Health Business Overview
  • 11.3.3 Merck Animal Health Veterinary Artificial Reproduction Introduction
  • 11.3.4 Merck Animal Health Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.3.5 Merck Animal Health Recent Development
• 11.4 CRV
  • 11.4.1 CRV Company Details
  • 11.4.2 CRV Business Overview
  • 11.4.3 CRV Veterinary Artificial Reproduction Introduction
  • 11.4.4 CRV Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.4.5 CRV Recent Development
• 11.5 URUS Group
  • 11.5.1 URUS Group Company Details
  • 11.5.2 URUS Group Business Overview
  • 11.5.3 URUS Group Veterinary Artificial Reproduction Introduction
  • 11.5.4 URUS Group Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.5.5 URUS Group Recent Development
• 11.6 ABS Global
  • 11.6.1 ABS Global Company Details
  • 11.6.2 ABS Global Business Overview
  • 11.6.3 ABS Global Veterinary Artificial Reproduction Introduction
  • 11.6.4 ABS Global Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.6.5 ABS Global Recent Development
• 11.7 Semex
  • 11.7.1 Semex Company Details
  • 11.7.2 Semex Business Overview
  • 11.7.3 Semex Veterinary Artificial Reproduction Introduction
  • 11.7.4 Semex Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.7.5 Semex Recent Development
• 11.8 Boehringer Ingelheim
  • 11.8.1 Boehringer Ingelheim Company Details
  • 11.8.2 Boehringer Ingelheim Business Overview
  • 11.8.3 Boehringer Ingelheim Veterinary Artificial Reproduction Introduction
  • 11.8.4 Boehringer Ingelheim Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.8.5 Boehringer Ingelheim Recent Development
• 11.9 Virbac
  • 11.9.1 Virbac Company Details
  • 11.9.2 Virbac Business Overview
  • 11.9.3 Virbac Veterinary Artificial Reproduction Introduction
  • 11.9.4 Virbac Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.9.5 Virbac Recent Development
• 11.10 JSR Genetics
  • 11.10.1 JSR Genetics Company Details
  • 11.10.2 JSR Genetics Business Overview
  • 11.10.3 JSR Genetics Veterinary Artificial Reproduction Introduction
  • 11.10.4 JSR Genetics Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.10.5 JSR Genetics Recent Development
• 11.11 HerdX
  • 11.11.1 HerdX Company Details
  • 11.11.2 HerdX Business Overview
  • 11.11.3 HerdX Veterinary Artificial Reproduction Introduction
  • 11.11.4 HerdX Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.11.5 HerdX Recent Development
• 11.12 Taurus
  • 11.12.1 Taurus Company Details
  • 11.12.2 Taurus Business Overview
  • 11.12.3 Taurus Veterinary Artificial Reproduction Introduction
  • 11.12.4 Taurus Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.12.5 Taurus Recent Development
• 11.13 Nandi Genetics
  • 11.13.1 Nandi Genetics Company Details
  • 11.13.2 Nandi Genetics Business Overview
  • 11.13.3 Nandi Genetics Veterinary Artificial Reproduction Introduction
  • 11.13.4 Nandi Genetics Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.13.5 Nandi Genetics Recent Development
• 11.14 Geno
  • 11.14.1 Geno Company Details
  • 11.14.2 Geno Business Overview
  • 11.14.3 Geno Veterinary Artificial Reproduction Introduction
  • 11.14.4 Geno Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.14.5 Geno Recent Development
• 11.15 AgriBio
  • 11.15.1 AgriBio Company Details
  • 11.15.2 AgriBio Business Overview
  • 11.15.3 AgriBio Veterinary Artificial Reproduction Introduction
  • 11.15.4 AgriBio Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.15.5 AgriBio Recent Development
• 11.16 CAHIC
  • 11.16.1 CAHIC Company Details
  • 11.16.2 CAHIC Business Overview
  • 11.16.3 CAHIC Veterinary Artificial Reproduction Introduction
  • 11.16.4 CAHIC Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.16.5 CAHIC Recent Development
• 11.17 Ruipu Biotech
  • 11.17.1 Ruipu Biotech Company Details
  • 11.17.2 Ruipu Biotech Business Overview
  • 11.17.3 Ruipu Biotech Veterinary Artificial Reproduction Introduction
  • 11.17.4 Ruipu Biotech Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.17.5 Ruipu Biotech Recent Development
• 11.18 Dahuanong
  • 11.18.1 Dahuanong Company Details
  • 11.18.2 Dahuanong Business Overview
  • 11.18.3 Dahuanong Veterinary Artificial Reproduction Introduction
  • 11.18.4 Dahuanong Revenue in Veterinary Artificial Reproduction Business (2020-2025)
  • 11.18.5 Dahuanong Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global Veterinary Artificial Reproduction Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Artificial Insemination

Table 3. Key Players of In Vitro Fertilization

Table 4. Key Players of Embryo Transfer

Table 5. Key Players of Other

Table 6. Global Veterinary Artificial Reproduction Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Veterinary Artificial Reproduction Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Market Size by Region (2020-2031) & (US$ Million)

Table 9. Global Veterinary Artificial Reproduction Market Share by Region (2020-2031)

Table 10. Market Trends

Table 11. Market Drivers

Table 12. Market Challenges

Table 13. Market Restraints

Table 14. Global Veterinary Artificial Reproduction Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Veterinary Artificial Reproduction Market Share by Players (2020-2025)

Table 16. Global Top Veterinary Artificial Reproduction Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Artificial Reproduction as of 2024)

Table 17. Global Veterinary Artificial Reproduction Industry Ranking 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Veterinary Artificial Reproduction Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Veterinary Artificial Reproduction, Headquarters and Area Served

Table 20. Global Key Players of Veterinary Artificial Reproduction, Product and Application

Table 21. Global Key Players of Veterinary Artificial Reproduction, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Veterinary Artificial Reproduction Revenue Market Share by Type (2020-2025)

Table 25. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Veterinary Artificial Reproduction Revenue Market Share by Type (2026-2031)

Table 27. Global Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Veterinary Artificial Reproduction Revenue Market Share by Application (2020-2025)

Table 29. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Veterinary Artificial Reproduction Revenue Market Share by Application (2026-2031)

Table 31. North America Market Size by Type (2020-2031) & (US$ Million)

Table 32. North America Market Size by Application (2020-2031) & (US$ Million)

Table 33. North America Veterinary Artificial Reproduction Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Market Size by Country (2020-2031) & (US$ Million)

Table 35. Europe Market Size by Type (2020-2031) & (US$ Million)

Table 36. Europe Market Size by Application (2020-2031) & (US$ Million)

Table 37. Europe Veterinary Artificial Reproduction Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Market Size by Country (2020-2025) & (US$ Million)

Table 39. China Market Size by Type (2020-2031) & (US$ Million)

Table 40. China Market Size by Application (2020-2031) & (US$ Million)

Table 41. Asia Market Size by Type (2020-2031) & (US$ Million)

Table 42. Asia Market Size by Application (2020-2025) & (US$ Million)

Table 43. Asia Veterinary Artificial Reproduction Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 44. Asia Market Size by Region (2020-2031) & (US$ Million)

Table 45. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)

Table 46. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)

Table 47. Middle East, Africa, and Latin America Veterinary Artificial Reproduction Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)

Table 49. Zoetis Company Details

Table 50. Zoetis Business Overview

Table 51. Zoetis Veterinary Artificial Reproduction Product

Table 52. Zoetis Revenue (2020-2025) & (US$ Million)

Table 53. Zoetis Recent Development

Table 54. Genus Company Details

Table 55. Genus Business Overview

Table 56. Genus Veterinary Artificial Reproduction Product

Table 57. Genus Revenue (2020-2025) & (US$ Million)

Table 58. Genus Recent Development

Table 59. Merck Animal Health Company Details

Table 60. Merck Animal Health Business Overview

Table 61. Merck Animal Health Veterinary Artificial Reproduction Product

Table 62. Merck Animal Health Revenue (2020-2025) & (US$ Million)

Table 63. Merck Animal Health Recent Development

Table 64. CRV Company Details

Table 65. CRV Business Overview

Table 66. CRV Veterinary Artificial Reproduction Product

Table 67. CRV Revenue (2020-2025) & (US$ Million)

Table 68. CRV Recent Development

Table 69. URUS Group Company Details

Table 70. URUS Group Business Overview

Table 71. URUS Group Veterinary Artificial Reproduction Product

Table 72. URUS Group Revenue (2020-2025) & (US$ Million)

Table 73. URUS Group Recent Development

Table 74. ABS Global Company Details

Table 75. ABS Global Business Overview

Table 76. ABS Global Veterinary Artificial Reproduction Product

Table 77. ABS Global Revenue (2020-2025) & (US$ Million)

Table 78. ABS Global Recent Development

Table 79. Semex Company Details

Table 80. Semex Business Overview

Table 81. Semex Veterinary Artificial Reproduction Product

Table 82. Semex Revenue (2020-2025) & (US$ Million)

Table 83. Semex Recent Development

Table 84. Boehringer Ingelheim Company Details

Table 85. Boehringer Ingelheim Business Overview

Table 86. Boehringer Ingelheim Veterinary Artificial Reproduction Product

Table 87. Boehringer Ingelheim Revenue (2020-2025) & (US$ Million)

Table 88. Boehringer Ingelheim Recent Development

Table 89. Virbac Company Details

Table 90. Virbac Business Overview

Table 91. Virbac Veterinary Artificial Reproduction Product

Table 92. Virbac Revenue (2020-2025) & (US$ Million)

Table 93. Virbac Recent Development

Table 94. JSR Genetics Company Details

Table 95. JSR Genetics Business Overview

Table 96. JSR Genetics Veterinary Artificial Reproduction Product

Table 97. JSR Genetics Revenue (2020-2025) & (US$ Million)

Table 98. JSR Genetics Recent Development

Table 99. HerdX Company Details

Table 100. HerdX Business Overview

Table 101. HerdX Veterinary Artificial Reproduction Product

Table 102. HerdX Revenue (2020-2025) & (US$ Million)

Table 103. HerdX Recent Development

Table 104. Taurus Company Details

Table 105. Taurus Business Overview

Table 106. Taurus Veterinary Artificial Reproduction Product

Table 107. Taurus Revenue (2020-2025) & (US$ Million)

Table 108. Taurus Recent Development

Table 109. Nandi Genetics Company Details

Table 110. Nandi Genetics Business Overview

Table 111. Nandi Genetics Veterinary Artificial Reproduction Product

Table 112. Nandi Genetics Revenue (2020-2025) & (US$ Million)

Table 113. Nandi Genetics Recent Development

Table 114. Geno Company Details

Table 115. Geno Business Overview

Table 116. Geno Veterinary Artificial Reproduction Product

Table 117. Geno Revenue (2020-2025) & (US$ Million)

Table 118. Geno Recent Development

Table 119. AgriBio Company Details

Table 120. AgriBio Business Overview

Table 121. AgriBio Veterinary Artificial Reproduction Product

Table 122. AgriBio Revenue (2020-2025) & (US$ Million)

Table 123. AgriBio Recent Development

Table 124. CAHIC Company Details

Table 125. CAHIC Business Overview

Table 126. CAHIC Veterinary Artificial Reproduction Product

Table 127. CAHIC Revenue (2020-2025) & (US$ Million)

Table 128. CAHIC Recent Development

Table 129. Ruipu Biotech Company Details

Table 130. Ruipu Biotech Business Overview

Table 131. Ruipu Biotech Veterinary Artificial Reproduction Product

Table 132. Ruipu Biotech Revenue (2020-2025) & (US$ Million)

Table 133. Ruipu Biotech Recent Development

Table 134. Dahuanong Company Details

Table 135. Dahuanong Business Overview

Table 136. Dahuanong Veterinary Artificial Reproduction Product

Table 137. Dahuanong Revenue (2020-2025) & (US$ Million)

Table 138. Dahuanong Recent Development

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Veterinary Artificial Reproduction Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 2. Global Veterinary Artificial Reproduction Market Share by Type: 2024 VS 2031

Figure 3. Artificial Insemination Features

Figure 4. In Vitro Fertilization Features

Figure 5. Embryo Transfer Features

Figure 6. Other Features

Figure 7. Global Veterinary Artificial Reproduction Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Global Veterinary Artificial Reproduction Market Share by Application: 2024 VS 2031

Figure 9. Livestock Case Studies

Figure 10. Companion Animal Case Studies

Figure 11. Veterinary Artificial Reproduction Report Years Considered

Figure 12. Global Veterinary Artificial Reproduction Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Veterinary Artificial Reproduction Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Veterinary Artificial Reproduction Market Share by Region: 2024 VS 2031

Figure 15. Global Veterinary Artificial Reproduction Market Share by Players in 2024

Figure 16. Global Top Veterinary Artificial Reproduction Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Artificial Reproduction as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Veterinary Artificial Reproduction Revenue in 2024

Figure 18. North America Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Veterinary Artificial Reproduction Market Share by Type (2020-2031)

Figure 20. North America Veterinary Artificial Reproduction Market Share by Application (2020-2031)

Figure 21. North America Veterinary Artificial Reproduction Market Share by Country (2020-2031)

Figure 22. United States Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Veterinary Artificial Reproduction Market Share by Type (2020-2031)

Figure 26. Europe Veterinary Artificial Reproduction Market Share by Application (2020-2031)

Figure 27. Europe Veterinary Artificial Reproduction Market Share by Country (2020-2031)

Figure 28. Germany Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. China Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. China Veterinary Artificial Reproduction Market Share by Type (2020-2031)

Figure 36. China Veterinary Artificial Reproduction Market Share by Application (2020-2031)

Figure 37. Asia Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia Veterinary Artificial Reproduction Market Share by Type (2020-2031)

Figure 39. Asia Veterinary Artificial Reproduction Market Share by Application (2020-2031)

Figure 40. Asia Veterinary Artificial Reproduction Market Share by Region (2020-2031)

Figure 41. Japan Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. South Korea Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. China Taiwan Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Southeast Asia Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. India Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Australia Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Veterinary Artificial Reproduction Market Share by Type (2020-2031)

Figure 49. Middle East, Africa, and Latin America Veterinary Artificial Reproduction Market Share by Application (2020-2031)

Figure 50. Middle East, Africa, and Latin America Veterinary Artificial Reproduction Market Share by Country (2020-2031)

Figure 51. Brazil Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Mexico Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Turkey Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Israel Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. GCC Countries Veterinary Artificial Reproduction Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Zoetis Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 58. Genus Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 59. Merck Animal Health Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 60. CRV Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 61. URUS Group Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 62. ABS Global Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 63. Semex Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 64. Boehringer Ingelheim Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 65. Virbac Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 66. JSR Genetics Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 67. HerdX Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 68. Taurus Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 69. Nandi Genetics Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 70. Geno Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 71. AgriBio Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 72. CAHIC Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 73. Ruipu Biotech Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 74. Dahuanong Revenue Growth Rate in Veterinary Artificial Reproduction Business (2020-2025)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed